← Leaderboards
Ambika Goel Bajpayee
Northeastern University
$3,562,555
Attributed
$3,816,670
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,816,670 · 4
By mechanism
R01$2,523,439 · 1
R21$1,136,231 · 2
R03$157,000 · 1
Top collaborators
- Nadeen O. Chahine3 shared
Others in their field
Other Emerging Leaders on “Penetration”
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$11,907,032
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- Thomas Dick · Rbhs-New Jersey Medical School$10,715,746
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$7,356,765
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,064,669
Research focus
PenetrationChargeCellsDoseDrug Delivery SystemsElectrostaticsRattusPharmaceutical PreparationsTissuesIntervertebral Disc StructureDesignIn VivoDensityInjuryPropertyBindingBiologicalEngineeringResidenceInflammatoryCytokineJointsMediatingCartilage
Grant awards (14)
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$383,356
R01 · FY2025 · AR · contact PI
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$424,564
R01 · FY2024 · AR · contact PI
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$422,560
R01 · FY2023 · AR · contact PI
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$421,167
R01 · FY2023 · AR · contact PI
Sustained Delivery of RhoA activator for Treatment of Intervertebral Disc Degeneration$191,184
R21 · FY2023 · AR
Sustained Delivery of RhoA activator for Treatment of Intervertebral Disc Degeneration$95,112
R21 · FY2023 · AR
Sustained Delivery of RhoA activator for Treatment of Intervertebral Disc Degeneration$221,935
R21 · FY2022 · AR
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$410,607
R01 · FY2021 · AR · contact PI
Anti-catabolic drug anchored cationic exosomes for cartilage targeting and repair$235,500
R21 · FY2021 · EB · contact PI
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues$461,185
R01 · FY2020 · AR · contact PI
Anti-catabolic drug anchored cationic exosomes for cartilage targeting and repair$196,250
R21 · FY2020 · EB · contact PI
Anti-catabolic drug anchored cationic exosomes for cartilage targeting and repair$196,250
R21 · FY2019 · EB · contact PI
Charge driven contrast enhanced computed tomography for imaging negatively charged tissues$78,500
R03 · FY2019 · EB · contact PI
Charge driven contrast enhanced computed tomography for imaging negatively charged tissues$78,500
R03 · FY2018 · EB · contact PI